Agios Pharmaceuticals, Inc. ( AGIO ) was a big mover last session, as the company saw its shares rise nearly 28% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. The stock picked up sharply from the near-flat trend of $35.16 to $36.15 since Mar 24, 2014.
The company has seen two negative estimate revisions in the past 30 days, while its Zacks Consensus Estimate moved lower over the same time frame, suggesting trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.
Agios Pharmaceuticals currently has a Zacks Rank #5 (Strong Sell) while its Earnings ESP is 0.00%.
Some better-ranked medical stocks that are worth considering include Enzymotec Ltd. ( ENZY ) and Covidien plc ( COV ). While Enzymotec sports a Zacks Rank #1 (Strong Buy), Covidien has a Zacks Ra nk #2 (Buy). Another stock worth considering in the broader healthcare industry is Alkermes plc ( ALKS ) with the same Zacks Rank as Enzymotec.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>
AGIOS PHARMACT (AGIO): Free Stock Analysis Report
ALKERMES INC (ALKS): Free Stock Analysis Report
COVIDIEN PLC (COV): Free Stock Analysis Report
ENZYMOTEC LTD (ENZY): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research